24 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34347217 | Association between ABCC2 polymorphism and hematological toxicity in patients with esophageal cancer receiving platinum plus 5-fluorouracil therapy. | 2022 Jan | 1 |
2 | 35053335 | TFEB Regulates ATP7B Expression to Promote Platinum Chemoresistance in Human Ovarian Cancer Cells. | 2022 Jan 10 | 4 |
3 | 33411033 | Effects of SLC31A1 and ATP7B polymorphisms on platinum resistance in patients with esophageal squamous cell carcinoma receiving neoadjuvant chemoradiotherapy. | 2021 Jan 7 | 1 |
4 | 32006874 | The expression of copper transporters associated with the ototoxicity induced by platinum-based chemotherapeutic agents. | 2020 Mar 15 | 1 |
5 | 32570116 | The contribution of copper efflux transporters ATP7A and ATP7B to chemoresistance and personalized medicine in ovarian cancer. | 2020 Sep | 2 |
6 | 31790150 | Copper-dependent ATP7B up-regulation drives the resistance of TMEM16A-overexpressing head-and-neck cancer models to platinum toxicity. | 2019 Dec 19 | 3 |
7 | 29394468 | Copper efflux transporters ATP7A and ATP7B: Novel biomarkers for platinum drug resistance and targets for therapy. | 2018 Mar | 2 |
8 | 29970670 | ATP7B rs9535826 is associated with gastrointestinal toxicity of platinum-based chemotherapy in nonsmall cell lung cancer patients. | 2018 | 4 |
9 | 30310510 | Gene expression and single nucleotide polymorphism of ATP7B are associated with platinum-based chemotherapy response in non-small cell lung cancer patients. | 2018 | 7 |
10 | 28737129 | Association between polymorphisms in CTR1, CTR2, ATP7A, and ATP7B and platinum resistance in epithelial ovarian cancer. | 2017 Oct | 1 |
11 | 27748801 | Acquisition of anticancer drug resistance is partially associated with cancer stemness in human colon cancer cells. | 2016 Dec | 1 |
12 | 24852429 | The ATP7B genetic polymorphisms predict clinical outcome to platinum-based chemotherapy in lung cancer patients. | 2014 Aug | 8 |
13 | 25242165 | Biochemical characterization of P-type copper ATPases. | 2014 Oct 15 | 1 |
14 | 23751120 | Copper chaperone Atox1 interacts with the metal-binding domain of Wilson's disease protein in cisplatin detoxification. | 2013 Aug 15 | 1 |
15 | 24023303 | Utility of ATP7B in prediction of response to platinum-based chemotherapy in urothelial bladder cancer. | 2013 Sep | 2 |
16 | 21455266 | Mechanism of tumor resistance to cisplatin mediated by the copper transporter ATP7B. | 2011 Apr | 1 |
17 | 22966294 | ATP7B expression is associated with in vitro sensitivity to cisplatin in non-small cell lung cancer. | 2010 Mar | 1 |
18 | 19296535 | Increased levels of copper efflux transporter ATP7B are associated with poor outcome in colorectal cancer patients receiving oxaliplatin-based chemotherapy. | 2009 Jun 15 | 1 |
19 | 19470734 | Therapeutic Targeting of ATP7B in Ovarian Carcinoma. | 2009 Jun 1 | 1 |
20 | 19509135 | Copper transporter 2 regulates the cellular accumulation and cytotoxicity of Cisplatin and Carboplatin. | 2009 Jul 1 | 1 |
21 | 20045993 | Genetic polymorphisms of copper- and platinum drug-efflux transporters ATP7A and ATP7B in Japanese cancer patients. | 2009 | 1 |
22 | 18636185 | Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) correlates with cisplatin resistance in human non-small cell lung cancer xenografts. | 2008 Aug | 2 |
23 | 15213293 | Modulation of the cellular pharmacology of cisplatin and its analogs by the copper exporters ATP7A and ATP7B. | 2004 Jul | 1 |
24 | 15240550 | Confocal microscopic analysis of the interaction between cisplatin and the copper transporter ATP7B in human ovarian carcinoma cells. | 2004 Jul 1 | 1 |